Xilis
Xilis, Inc.
Xilis, Inc. is a biotech company focused on transforming cancer treatment through innovative technologies that enable personalized medicine. By leveraging its proprietary MicroOrganoSphere™ technology, Xilis offers tailored therapeutic solutions that match cancer patients with the most effective treatments based on their individual tumor biology.
Products & Team
MicroOrganoSphere™ (MOS) Technology
The MicroOrganoSphere™ (MOS) technology allows the creation of miniature tumor models that preserve the critical biological characteristics of the original tumor. These microscale tumors enable clinicians to test various cancer therapies to determine which are most effective for individual patients.
Xilis solves the challenge of generalized cancer treatments by providing personalized therapy recommendations that are based on the unique biology of each patient's tumor, thereby enhancing treatment efficacy.
Traditional cancer treatments often fail to account for individual variability in tumor biology, leading to ineffective therapies for patients.